Nemera discusses how its e-Novelia system is helping increase adherence for ophthalmology patients.
Digital eye
It’s well known that the quality and success of a treatment can depend on patients’ adherence.
In 2016, the estimation of the revenues lost globally by pharma due to non-adherence was $637bn. In the case of ophthalmic therapy, the quality and safety of eye drop use for patients treated in a healthcare setting play a vital role in the delivery of healthcare.